🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Estrogen

The Effects of Night Shift Work on Health Across the Menstrual Cycle NCT06683248NA1 site📍 Uppsala Uppsala University · Tests: Investigate sleep deprivation Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer NCT06072807Phase 41 site📍 New York Weill Medical College of Cornell University · Tests: Brain Imaging with 18F-FES Estrogen Supplementation and Bone Health in Women With CF NCT05704036Phase 41 site📍 Baltimore Johns Hopkins University · Tests: Transdermal estrogen, Progesterone Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer NCT05541367n/a1 site📍 Wuhan Tongji Hospital A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors NCT07318805Phase 113 sites📍 Duarte📍 Grand Rapids📍 Long Island City Pfizer · Tests: PF-08032562, Fulvestrant, Cetuximab, Fluorouracil, Oxaliplatin Negative Emotionality and Epigenetics During Puberty NCT06690866n/a1 site📍 Tübingen International Research Training Group 2804 · Tests: Stress Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea NCT06533865Phase 32 sites📍 Boston📍 Charlottesville Massachusetts General Hospital · Tests: Romosozumab, Placebo, Zoledronic acid The REgistry of Very Early Estrogen and AnovuLation NCT06583408n/a2 sites📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24), REVEAL Questionnaire Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions NCT07053982NA1 site📍 Toulouse University Hospital, Toulouse · Tests: Preoperative [18F]-FES PET/CT Imaging and Estrogen Receptor Expression Analysis in Endometriosis Surgery Role of Menopause in Thermoregulation NCT06798571Phase 41 site📍 University Park Penn State University · Tests: Elagolix Oral Tablet, Estradiol patch, cellulose placebo, placebo patch Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer NCT05872204Phase 212 sites📍 Liège📍 Ghent📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: Abemaciclib, Letrozole COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study NCT06704516Phase 11 site📍 Oxford University of Oxford · Tests: Menopausal hormone therapy Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer NCT02535221Phase 31 site📍 Beijing Peking University · Tests: Goserelin+TAM+AI, Epirubicin+CTX+5-Fu A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer NCT07100106Phase 1, Phase 277 sites📍 Huntsville📍 Tucson📍 Duarte Genentech, Inc. · Tests: GDC-4198, Giredestrant, Abemaciclib Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt) NCT06150898Phase 21 site📍 Brussels Jules Bordet Institute · Tests: Prospective data and sample collection, Ketorolac 10 Mg Oral Tablet, Pregabalin 75mg, Omeprazole 20mg Capsule Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in Males NCT07604272Phase 11 site📍 Chicago Northwestern University · Tests: Fulvestrant, Anastrozole (ARIMIDEX™) Serum Endogenous Estrogens, Estrogen Receptors, and Sirtuin-1 and -3 After Resveratrol Supplementation NCT07865377NA1 site📍 São Paulo InCor Heart Institute · Tests: Trans-resveratrol, 1000 mg daily for 90 days, Placebo Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor NCT05181033Phase 21 site📍 Singapore National University Hospital, Singapore · Tests: Lenvatinib + Letrozole, Fulvestrant Postpartum Vaginal Estrogen for Breastfeeding Patients NCT05457972Phase 41 site📍 Cleveland University Hospitals Cleveland Medical Center · Tests: Estradiol, Vaginal Moisturizer Estradiol and Intrusive Memories NCT07419594NA1 site📍 Berlin Charite University, Berlin, Germany · Tests: Estradiol Valerate, Placebo Improving Diagnostics in Cervical Dysplasia NCT05283421NA1 site📍 Randers University of Aarhus · Tests: Estrogen, Placebo A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. NCT07062965Phase 3433 sites📍 Anchorage📍 Chandler📍 Gilbert Pfizer · Tests: PF-07248144, Fulvestrant, Everolimus, Exemestane Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial NCT06184750Phase 211 sites📍 Tucson📍 Chicago📍 Chicago National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Mammography, Questionnaire Administration, Tamoxifen Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency NCT07361263NA1 site📍 Basel University Hospital, Basel, Switzerland · Tests: estradiol valerate, esthinylestradiol Effects of Estrogen on Muscle Gain During 12-weeks of Exercise in Post-menopausal Women NCT07617454NA1 site📍 Aarhus Mette Hansen · Tests: Estrogel, Physical exercise Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer NCT06260033Phase 22 sites📍 Duarte📍 Irvine City of Hope Medical Center · Tests: Biospecimen Collection, Bone Scan, Computed Tomography, F-18 16 Alpha-Fluoroestradiol, Positron Emission Tomography Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer NCT06062498Phase 23 sites📍 Chicago📍 Chicago📍 Chicago Northwestern University · Tests: elacestrant, palbociclib, abemaciclib, ribociclib Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial NCT07466498Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Androgen Receptor Pathway Inhibitor, Transdermal Estrogen, Bone Scan, Computed Tomography, Dual X-ray Absorptiometry OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk NCT05333328Phase 42 sites📍 Seoul📍 Seoul Gangnam Severance Hospital · Tests: Ovarian function suppression with endocrine treatments A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer NCT04872166Phase 16 sites📍 Lake Mary📍 Sarasota📍 Cincinnati Edgewood Oncology Inc. · Tests: BTX-A51
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy